|1.||Lee, Sang Kook: 6 articles (04/2015 - 01/2003)|
|2.||Kim, Sanghee: 5 articles (04/2015 - 11/2010)|
|3.||Song, Jayoung: 3 articles (04/2015 - 03/2012)|
|4.||Chung, Hwa-Jin: 3 articles (02/2013 - 11/2010)|
|5.||Kwon, Yongseok: 2 articles (04/2015 - 02/2013)|
|6.||Lin, Jau-Chen: 2 articles (03/2013 - 07/2011)|
|7.||Teng, Che-Ming: 2 articles (08/2012 - 07/2011)|
|8.||Lai, Chin-Yu: 2 articles (08/2012 - 07/2011)|
|9.||Pan, Shiow-Lin: 2 articles (08/2012 - 07/2011)|
|10.||Wu, Tian-Shung: 2 articles (08/2012 - 07/2011)|
03/01/2012 - "In this study, we further explored the potential of (-)-antofine to overcome the resistance induced by anti-cancer drugs. "
01/01/2003 - "Prompted by the high potency of cancer cell growth inhibition, additional action mechanism studies were performed with antofine. "
04/23/2015 - "These findings emphasize the potential of Met endosomal signaling as a novel target for Met TKI-resistant cancers and (-)-antofine as a novel lead compound associated with the suppression of Met endosomal signaling. "
01/01/2014 - "We have studied the anti-cancer activities of antofine N-oxide isolated and purified from the medicinal plant Cynanchum vincetoxicum. "
02/15/2013 - "New water soluble antofine C-13a analogues were designed, synthesized, and evaluated for antiproliferative activity against cancer cells. "
|4.||Breast Neoplasms (Breast Cancer)
|5.||Lung Neoplasms (Lung Cancer)
01/01/2003 - "Starting with an extract derived from the root of Cynanchum paniculatum Kitagawa (Asclepiadaceae) that was active in the process of inhibiting the growth of human cancer cells in culture, a phenanthroindolizidine alkaloid antofine was isolated and identified as an active principle (IC50 = 7.0 +/- 0.2 ng/ml for A549, human lung cancer cells; IC50 = 8.6 +/- 0.3 ng/ml for Col2, human colon cancer cells). "
03/01/2012 - "Anti-proliferative activity and suppression of P-glycoprotein by (-)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells."
|6.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|1.||Heterologous Transplantation (Xenotransplantation)